Wellington Management Group
AVNR

Wellington Management Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Wellington Management Group’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,675,514
Closed -$15.1M – 2308
2014
Q2 		$15.1M Buy
2,675,514
+78,780
+3% +$363K ﹤0.01% 1134
2014
Q1 		$9.53M Sell
2,596,734
-213,040
-8% -$812K ﹤0.01% 1268
2013
Q4 		$9.44M Sell
2,809,774
-1,748,036
-38% -$7.22M ﹤0.01% 1259
2013
Q3 		$19.3M Sell
4,557,810
-5,210,735
-53% -$24.7M 0.01% 1011
2013
Q2 		$44.9M Buy
+9,768,545
New +$33.6M 0.01% 725

Other funds holding AVNR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

Wellington Management Group's AVNR Position: Q3 2014 in Review

Wellington Management Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q3 2014, closing a stake of 2,675,514 shares — an estimated $15.1M sold.

Wellington Management Group first reported a position in AVNR in Q2 2013 and held it in 5 quarters. The position peaked at $44.9M in Q2 2013. 142 funds tracked by Wall St. Rank hold AVNR as of Q3 2014.

  • Wellington Management Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q3 2014 after selling out during the quarter.
  • Wellington Management Group sold 2,675,514 AVANIR PHARMACEUTICALS, INC CL A shares in Q3 2014, an estimated $15.1M.
  • Wellington Management Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 5 quarters.
  • Wellington Management Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $44.9M in Q2 2013.
  • 142 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q3 2014.

Based on Wellington Management Group's 13F filing for Q3 2014, filed 14 Nov 2014.